PHOENIX BIOTECH ACQUISITION EQUITY WARRANTS EXP 1ST SEP 2026 Insider Trades

PBAXW

Track insider trading activity from PHOENIX BIOTECH ACQUISITION EQUITY WARRANTS EXP 1ST SEP 2026 executives and directors. See which insiders are buying and selling PBAXW stock.

Trades Last 12 Months

PBAXW Price

All Insider Trades for PHOENIX BIOTECH ACQUISITION EQUITY WARRANTS EXP 1ST SEP 2026

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Atwood Brian G Director
Holding Value $1.5k 25,000 shares
Last Trade
Oct 08, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.06
Ehrlich Christopher B 10% owner, CEO And Secretary
Holding Value $42k 699,996 shares
Last Trade
Oct 08, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.06
Fisher Douglas President
Holding Value $6k 100,000 shares
Last Trade
Oct 08, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.06
Geffken Daniel E. Chief Financial Officer
Holding Value $1.8k 30,000 shares
Last Trade
Oct 08, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.06
Kosacz Barbara Director
Holding Value $1.05k 17,500 shares
Last Trade
Oct 08, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.06
Laporte Kathleen Director
Holding Value $1.05k 17,500 shares
Last Trade
Oct 08, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.06
Loewy Caroline M Director
Holding Value $1.05k 17,500 shares
Last Trade
Oct 08, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.06
Holding Value $42k 699,996 shares
Last Trade
Oct 08, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$0.06

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up